Michael F Mahoney Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 2 days, 3 hours ago
Michael F Mahoney has an estimated net worth of at least $309.6 million*, as of Feb. 19, 2025. They own 1.9 million shares of BSX stock. They have sold 2.1 million shares of BSX stock since 2021, for an estimated $114.4 million.
Michael F Mahoney $BSX SEC Form 4 Insider Trading
Michael F Mahoney has filed a total of 17 insider trades in $BSX since 2021. Their most recent trade was a sale of 2,596 shares, made on Nov 05, 2024. Their largest trade was a sale of 201,043 shares, made on Aug 02, 2021. We estimate that they now own 1.9 million shares of $BSX, worth an estimated $195.2 million.
Insider Trading at $BSX
There have been a total of 168 insider trades reported at $BSX since 2021, with 25,050 shares purchased and 4.5 million shares sold. The most active insider traders in $BSX stock have been Wendy Carruthers, Jeffrey B. Mirviss, and Michael F Mahoney. The most recent trade was a sale of 3,303 shares reported by John Bradley Sorenson (EVP, Global Operations), made on Feb 19, 2025.
History of Insider Stock Trades by Michael F Mahoney
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
CVS
|
Purchase | 30,000 | Feb 18, 2025 | Feb. 19, 2025, 1:35 p.m. |
BSX
|
Sale | 2,596 | Nov 05, 2024 | Nov. 7, 2024, 5:45 p.m. |
|
BSX
|
Sale | 160,182 | Nov 05, 2024 | Nov. 7, 2024, 5:45 p.m. |
|
BSX
|
Sale | 80,692 | Oct 07, 2024 | Oct. 8, 2024, 5:48 p.m. |
|
BSX
|
Sale | 82,085 | Oct 07, 2024 | Oct. 8, 2024, 5:48 p.m. |
|
BSX
|
Sale | 162,777 | Sep 05, 2024 | Sept. 6, 2024, 4:12 p.m. |
|
CVS
|
Purchase | 9,181 | May 02, 2024 | May 2, 2024, 4:30 p.m. |
|
BSX
|
Sale | 113,356 | Nov 06, 2023 | Nov. 7, 2023, 5:11 p.m. |
|
BSX
|
Sale | 113,355 | Oct 09, 2023 | Oct. 10, 2023, 6:11 p.m. |
|
BSX
|
Sale | 113,355 | Sep 12, 2023 | Sept. 12, 2023, 5:37 p.m. |
|
BSX
|
Sale | 125,827 | Nov 07, 2022 | Nov. 8, 2022, 5:43 p.m. |
|
BSX
|
Sale | 125,827 | Oct 03, 2022 | Oct. 4, 2022, 4:28 p.m. |
|
BSX
|
Sale | 125,828 | Sep 06, 2022 | Sept. 7, 2022, 4:32 p.m. |
|
BSX
|
Sale | 125,828 | Aug 08, 2022 | Aug. 9, 2022, 12:31 p.m. |
|
BSX
|
Sale | 201,042 | Nov 01, 2021 | Nov. 1, 2021, 8 p.m. |
|
BSX
|
Sale | 97,838 | Oct 04, 2021 | Oct. 4, 2021, 8 p.m. |
|
BSX
|
Sale | 103,204 | Oct 04, 2021 | Oct. 4, 2021, 8 p.m. |
|
BSX
|
Sale | 201,043 | Aug 02, 2021 | Aug. 3, 2021, 8 p.m. |
|
BSX
|
Sale | 201,041 | Jul 06, 2021 | July 7, 2021, 8 p.m. |
$BSX Executives and Stock Owners with Insider Trades
-
Wendy Carruthers, EVP, Human Resources
-
Jeffrey B. Mirviss, EVP&Pres, Periph Intervent
-
Michael F Mahoney, Chairman, President & CEO
-
Daniel J. Brennan, EVP and CFO
-
Arthur C Butcher, EVP& Grp Pres, MedSurg & APAC
-
Joseph Michael Fitzgerald, EVP & Group Pres, Cardiology
-
John Bradley Sorenson, EVP, Global Operations
-
Wendy Carruthers, SVP, Human Resources
-
David A Pierce, EVP Pres MedSurg
-
Jodi Euerle Eddy, SVP, Chief Info & Digital Off.
-
Eric Francis Yves Thepaut, EVP & Pres, Eur, Mid-East, Afr
-
Jonathan Monson, VP, Global Controller and CAO
-
Vance R Brown, SVP, GC and Corp. Secretary
-
Arthur C Butcher, EVP&Pres, Asia Pacific
-
Meghan Scanlon, SVP,Pres,Urology Pelvic Health
-
Scott Olson, SVP & Pres, CRM, Diagnostics
-
Scott Olson, SVP & Pres, Rhythm Management
-
Jonathan Monson, SVP, Global Controller and CAO
-
Ian T Meredith, EVP Global Chief Med Officer
-
John Bradley Sorenson, SVP, Global Supply Chain
-
Emily Woodworth, SVP, Global Controller and CAO
-
Joseph Michael Fitzgerald, EVP & Pres, Interven Cardio
-
Maulik Nanavaty, SVP & Pres, Neuromodulation
-
Edward F Mackey, EVP, Operations
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.